Rivastigmine Tartrate

Product NDC
0591-3209
11-digit product format
005913209
Labeler code
0591
Product ID
0591-3209_b7365bec-a71e-4aa8-a5ee-26b9c5ff9058
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Rivastigmine Tartrate
Dosage form
CAPSULE
Route
ORAL
Labeler
Actavis Pharma, Inc.
Application
ANDA077129
Marketing category
ANDA
Marketing start
2010-07-01
Marketing end
2020-10-31
Substance
RIVASTIGMINE TARTRATE
Active strength
3 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0591-3209-60EA - Each0591-3209abc1c233-c65b-4b77-a91b-738a9177ac3112012-07-24